HIV Transmission

被引:179
作者
Shaw, George M. [1 ]
Hunter, Eric [2 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA
[2] Emory Univ, Dept Pathol & Lab Med, Emory Vaccine Ctr, Atlanta, GA 30329 USA
来源
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE | 2012年 / 2卷 / 11期
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL DEPLETION; HUMAN CERVICAL TISSUE; MALE CIRCUMCISION; EX-VIVO; SEXUAL TRANSMISSION; TYPE-1; INFECTION; RHESUS MACAQUES; VIRAL DYNAMICS; HETEROSEXUAL TRANSMISSION;
D O I
10.1101/cshperspect.a006965
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
HIV-1 is transmitted by sexual contact across mucosal surfaces, by maternal-infant exposure, and by percutaneous inoculation. For reasons that are still incompletely understood, CCR5-tropic viruses (R5 viruses) are preferentially transmitted by all routes. Transmission is followed by an orderly appearance of viral and host markers of infection in the blood plasma. In the acute phase of infection, HIV-1 replicates exponentially and diversifies randomly, allowing for an unambiguous molecular identification of transmitted/founder virus genomes and a precise characterization of the population bottleneck to virus transmission. Sexual transmission of HIV-1 most often results in productive clinical infection arising from a single virus, highlighting the extreme bottleneck and inherent inefficiency in virus transmission. It remains to be determined if HIV-1 transmission is largely a stochastic process where by any reasonably fit R5 virus can be transmitted or if there are features of transmitted/founder viruses that facilitate their transmission in a biologically meaningful way. Human tissue explant models of HIV-1 infection and animal models of SIV/SHIV/HIV-1 transmission, coupled with new challenge virus strains that more closely reflect transmitted/founder viruses, have the potential to elucidate fundamental mechanisms in HIV-1 transmission relevant to vaccine design and other prevention strategies.
引用
收藏
页数:23
相关论文
共 144 条
[1]   Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants [J].
Abrahams, M. -R. ;
Anderson, J. A. ;
Giorgi, E. E. ;
Seoighe, C. ;
Mlisana, K. ;
Ping, L. -H. ;
Athreya, G. S. ;
Treurnicht, F. K. ;
Keele, B. F. ;
Wood, N. ;
Salazar-Gonzalez, J. F. ;
Bhattacharya, T. ;
Chu, H. ;
Hoffman, I. ;
Galvin, S. ;
Mapanje, C. ;
Kazembe, P. ;
Thebus, R. ;
Fiscus, S. ;
Hide, W. ;
Cohen, M. S. ;
Karim, S. Abdool ;
Haynes, B. F. ;
Shaw, G. M. ;
Hahn, B. H. ;
Korber, B. T. ;
Swanstrom, R. ;
Williamson, C. .
JOURNAL OF VIROLOGY, 2009, 83 (08) :3556-3567
[2]   Donor and Recipient Envs from Heterosexual Human Immunodeficiency Virus Subtype C Transmission Pairs Require High Receptor Levels for Entry [J].
Alexander, Melissa ;
Lynch, Rebecca ;
Mulenga, Joseph ;
Allen, Susan ;
Derdeyn, Cynthia A. ;
Hunter, Eric .
JOURNAL OF VIROLOGY, 2010, 84 (08) :4100-4104
[3]  
[Anonymous], GLOB REP 2010
[4]  
[Anonymous], J VIROL IN PRESS
[5]  
[Anonymous], AM J REPROD IMMUNOL
[6]   HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells [J].
Arthos, James ;
Cicala, Claudia ;
Martinelli, Elena ;
Macleod, Katilyn ;
Van Ryk, Donald ;
Wei, Danlan ;
Xiao, Zhen ;
Veenstra, Timothy D. ;
Conrad, Thomas P. ;
Lempicki, Richard A. ;
McLaughlin, Sherry ;
Pascuccio, Massimiliano ;
Gopaul, Ravindra ;
McNally, Jonathan ;
Cruz, Catherine C. ;
Censoplano, Nina ;
Chung, Eva ;
Reitano, Kristin N. ;
Kottilil, Shyam ;
Goode, Diana J. ;
Fauci, Anthony S. .
NATURE IMMUNOLOGY, 2008, 9 (03) :301-309
[7]   A Signature in HIV-1 Envelope Leader Peptide Associated with Transition from Acute to Chronic Infection Impacts Envelope Processing and Infectivity [J].
Asmal, Mohammed ;
Hellmann, Ina ;
Liu, Weimin ;
Keele, Brandon F. ;
Perelson, Alan S. ;
Bhattacharya, Tanmoy ;
Gnanakaran, S. ;
Daniels, Marcus ;
Haynes, Barton F. ;
Korber, Bette T. ;
Hahn, Beatrice H. ;
Shaw, George M. ;
Letvin, Norman L. .
PLOS ONE, 2011, 6 (08)
[8]   Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial [J].
Auvert, B ;
Taljaard, D ;
Lagarde, E ;
Sobngwi-Tambekou, J ;
Sitta, M ;
Puren, A .
PLOS MEDICINE, 2005, 2 (11) :1112-1122
[9]   Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial [J].
Bailey, Robert C. ;
Moses, Stephen ;
Parker, Corette B. ;
Agot, Kawango ;
Maclean, Ian ;
Krieger, John N. ;
Williams, Carolyn F. M. ;
Campbell, Richard T. ;
Ninya-Achola, Jeckoniah O. .
LANCET, 2007, 369 (9562) :643-656
[10]   Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users [J].
Bar, Katharine J. ;
Li, Hui ;
Chamberland, Annie ;
Tremblay, Cecile ;
Routy, Jean Pierre ;
Grayson, Truman ;
Sun, Chuanxi ;
Wang, Shuyi ;
Learn, Gerald H. ;
Morgan, Charity J. ;
Schumacher, Joseph E. ;
Haynes, Barton F. ;
Keele, Brandon F. ;
Hahn, Beatrice H. ;
Shaw, George M. .
JOURNAL OF VIROLOGY, 2010, 84 (12) :6241-6247